Electroresponsive pulsatile depot delivery of insulin from poly(dimethylaminopropylacrylamide) gel in rats.

We describe a model for pulsatile drug delivery with an electroresponsive polymer that is stimulated by an externally applied electrical field. Insulin loaded in an electroresponsive poly(dimethylaminopropylacrylamide) (PDMAPAA) gel was administered as a subcutaneous depot in rats. The gel induced a pulsatile plasma glucose decrease in correspondence to stimulation with a constant current of 1.0 mA (0.36 mA/cm2). The first drop occurred at 0.5 h after a 1-min application of current at 0 h and the second drop occurred at 3 h after a 10-min application of current at 2 h. Calculation of pharmacological bioavailability showed that the gel released 0.12% of the loaded insulin after these two stimuli. This in vivo study demonstrates the feasibility of this pulsatile delivery system. The mechanism of insulin release from the electroresponsive PDMAPAA gel is associated with electrokinetic flow of solvated insulin with water; that is, transportation process of counterions (electrophoresis) and water molecules (electroosmosis) in the crosslinked polyelectrolyte gel network.

[1]  H. Abramson Skin reactions: X. Preseasonal treatment of hay fever by electrophoresis of ragweed pollen extracts into the skin: Preliminary report , 1941 .

[2]  P. Jeffrey,et al.  An Equilibrium Ultracentrifuge Study of the Effect of Ionic Strength on the Self-Association of Bovine Insulin* , 1966 .

[3]  Y. Takatsuka,et al.  Effect of surfactants on the nasal absorption of insulin in rats , 1981 .

[4]  J. Jansson,et al.  Intravenous growth hormone: growth responses to patterned infusions in hypophysectomized rats. , 1985, The Journal of endocrinology.

[5]  G. Chrousos,et al.  Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern. , 1986, The Journal of clinical endocrinology and metabolism.

[6]  Allan S. Hoffman,et al.  Applications of thermally reversible polymers and hydrogels in therapeutics and diagnostics , 1987 .

[7]  J. Kost,et al.  Magnetically enhanced insulin release in diabetic rats. , 1987, Journal of biomedical materials research.

[8]  B. Tarquini,et al.  Prominent circadian absorption of intranasal salmon calcitonin (SCT) in healthy subjects. , 1988, Chronobiology international.

[9]  R. Siegel,et al.  pH-Controlled release from hydrophobic/polyelectrolyte copolymer hydrogels , 1988 .

[10]  R. Clark,et al.  Growth hormone (GH) secretion in the conscious rat: negative feedback of GH on its own release. , 1988, The Journal of endocrinology.

[11]  Yoshihito Osada,et al.  Reversible volume change of microparticles in an electric field , 1989 .

[12]  K. Sawahata,et al.  Electrically controlled drug delivery system using polyelectrolyte gels , 1990 .

[13]  W. Shi,et al.  Facilitated transdermal delivery of therapeutic peptides and proteins by iontophoretic delivery devices , 1990 .

[14]  Mechanism and process of chemomechanical contraction of polyelectrolyte gels under electric field , 1990 .

[15]  T. Okano,et al.  Drug release from electric current sensitive polymers , 1991 .

[16]  R. Guy,et al.  In vitro and in vivo iontophoresis of a tripeptide across nude rat skin , 1992 .

[17]  J. Feijen,et al.  Heparin release from thermosensitive hydrogels , 1992 .

[18]  P. Teitelbaum,et al.  Preformed porous microspheres for controlled and pulsed release of macromolecules , 1993 .

[19]  A. Banga,et al.  Characterization of in Vitro Transdermal Iontophoretic Delivery of Insulin , 1993 .

[20]  F. Moll,et al.  In vitro pulsatile and continuous transdermal delivery of buserelin by iontophoresis , 1993 .

[21]  CONTROLLED RELEASE OF INSULIN FROM BORONIC ACID GEL UNDER PHYSIOLOGICAL CONDITIONS , 1994 .

[22]  J. Gong,et al.  Electrokinetic Modeling of the Contractile Phenomena of Polyelectrolyte Gels. One-Dimensional Capillary Model , 1994 .

[23]  Y. Bae,et al.  Heparin release from polymer complex , 1994 .

[24]  Electrically controlled release of macromolecules from cross-linked hyaluronic acid hydrogels , 1995 .

[25]  R. Potts,et al.  Pulsatile transdermal delivery of LHRH using electroporation: Drug delivery and skin toxicology , 1995 .

[26]  Susan Budavari,et al.  The Merck index , 1998 .